Register
Login:
Share:
Email Facebook Twitter

Cornhill Capital sees strong investor enthusiasm in London IPOs Watch here

Cornhill Capital sees strong investor enthusiasm in London IPOs


Glaxosmithkline Share Price (GSK)



Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,550.00Bid: 1,550.00Ask: 1,551.00Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 1.00Spread as %: 0.06%Open: 1,556.00High: 1,558.00Low: 1,544.00Yesterday’s Close: 1,550.00

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1550.00

Share Price SpacerBid
1550.00

Share Price SpacerAsk
1551.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
10,210,779

Share Price SpacerOpen
1,556.00

Share Price SpacerHigh
1,558.00

Share Price SpacerLow
1,544.00

Share Price SpacerClose
1,550.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,910.11m £76,106.71m 1,500

52 Week High 1,735.50 52 Week High Date 11-OCT-2016
52 Week Low 1,363.00 52 Week Low Date 24-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
11,852 6,875,676 3,187,522 82.447 18.80 80.00 5.16


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: BP, Lloyds, Vodafone, Tesco, Barclays, Royal Bank of Scotland, HSBC, National Grid, Aviva, BT

Users who hold GSK also hold: Vodafone, BP, National Grid, Lloyds, Tesco, Royal Dutch Shell B, HSBC, Aviva, BT, Centrica


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Apr-17
17:04:45
1,550.3389
19,816
Sell* 
1,550.00
1,551.00
307.22k
Trade Type:
Ordinary
Deletion
Bargain conditions apply

28-Apr-17
17:04:45
1,550.3384
13,059
Sell* 
1,550.00
1,551.00
202.46k
Trade Type:
Ordinary
Deletion
Bargain conditions apply

28-Apr-17
17:04:45
1,550.3373
7,738
Sell* 
1,550.00
1,551.00
119.97k
Trade Type:
Ordinary
Deletion
Bargain conditions apply




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
26-Apr-17Buy
Trade Notifier Information for GlaxoSmithKline
Sir Roy Anderson held the position of Independent Non-Executive Director at GlaxoSmithKline at the time of this trade.
 Sir Roy Anderson
1583GBX4541172347
26-Apr-17Buy
Trade Notifier Information for GlaxoSmithKline
Philip R Hampton held the position of Non-Executive Chairman at GlaxoSmithKline at the time of this trade.
 Philip R Hampton
1583GBX2,7638744654
26-Apr-17Buy
Trade Notifier Information for GlaxoSmithKline
Vivienne Cox held the position of Independent Non-Executive Director at GlaxoSmithKline at the time of this trade.
 Vivienne Cox
1583GBX335346
View more Glaxosmithkline directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Thu 12:17Gerry557RE: gsk1,546.00No Opinion
"(hard to see what it adds really to funds already available.)"

Spikeyj, nothing to you or me but it helps Woody's bonus an awful lot. Still he can boast about his long term reputation for a while longer and diss any short term losses for a few years anyway.

I suspect there will be a few having second thoughts after recent struggles in one of his funds but that is what happens when people give you wadges of dosh to invest for them. You invest it no matter what rather than wait… Read More
Thu 11:31AndyagogoTOUGH1,546.50No Opinion
reaction.

There looked multiple upsides to me.

Have seen some comment that Andrew Witty was a better presenter and really sold GSK's
longer term prospects, was that perhaps lacking yesterday with Emma?.
Thu 08:36Spikeyjtough1,553.50No Opinion
reception to those results continues.

welcome to the top chair, emma.
Wed 18:11SpikeyjRE: gsk1,566.00No Opinion
that new fund has not been particularly well subscribed.
(hard to see what it adds really to funds already available.)
Wed 18:10AndyagogoRE: gsk1,566.00Strong Buy
Ah there was a caveat to that - will keep this structure under regular review.

However I can see the benefits of pharma and vaccines combined.
On consumer consumer products hopefully NVS sell their share.

New CEO seems to be very returns focussed, a benefit to shareholders,
Stronger on commercial focus than Andrew?.
Wed 17:45Gerry557RE: gsk1,566.00No Opinion
That will upset Woody although I bet he will be buying loads anyway for the new fund.

Market didnt like the report

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Glaxosmithkline (GSK) >>

Please login or register to post a message on Share Chat.





Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline - Redirect



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.